HQP8361

凯泰酮胺

Report date: 2024/01/18 20:05:22
NME

Base Information

Drug NameHQP8361
Drug Alias Namekaitai ketoamineAPG-8361MK-8033HQP-8361
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitorsMacrophage-stimulating protein receptor inhibitors
TargetsHepatocyte growth factor receptorMacrophage-stimulating protein receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesMerck & Co Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesGuangzhou Shunjian Biomedical Technology Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A